Search

Deirdre Renee Claytor

Supervisory Patent Examiner (ID: 19287, Phone: (571)272-8394 , Office: P/1651 )

Most Active Art Unit
1627
Art Unit(s)
1617, 1627, 1651, 1691
Total Applications
768
Issued Applications
255
Pending Applications
49
Abandoned Applications
466

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6178209 [patent_doc_number] => 20110178179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => '1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COGNITIVE IMPAIRMENT IN TINNITUS' [patent_app_type] => utility [patent_app_number] => 12/998033 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11299 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178179.pdf [firstpage_image] =>[orig_patent_app_number] => 12998033 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/998033
1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COGNITIVE IMPAIRMENT IN TINNITUS Sep 1, 2009 Abandoned
Array ( [id] => 5373635 [patent_doc_number] => 20090311196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'PHARMACEUTICAL AEROSOL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/547534 [patent_app_country] => US [patent_app_date] => 2009-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5861 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311196.pdf [firstpage_image] =>[orig_patent_app_number] => 12547534 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/547534
Pharmaceutical aerosol composition Aug 25, 2009 Issued
Array ( [id] => 6548285 [patent_doc_number] => 20100222376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'CHELERYTHRINE, ANALOGS THEREOF AND THEIR USE IN THE TREATMENT OF BIPOLAR DISORDER AND OTHER COGNITIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/546737 [patent_app_country] => US [patent_app_date] => 2009-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7150 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222376.pdf [firstpage_image] =>[orig_patent_app_number] => 12546737 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/546737
CHELERYTHRINE, ANALOGS THEREOF AND THEIR USE IN THE TREATMENT OF BIPOLAR DISORDER AND OTHER COGNITIVE DISORDERS Aug 24, 2009 Abandoned
Array ( [id] => 6048603 [patent_doc_number] => 20110207718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/057628 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32596 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207718.pdf [firstpage_image] =>[orig_patent_app_number] => 13057628 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/057628
COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC DISORDERS Aug 5, 2009 Abandoned
Array ( [id] => 6636663 [patent_doc_number] => 20100035845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'TIGECYCLINE FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/535957 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7060 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035845.pdf [firstpage_image] =>[orig_patent_app_number] => 12535957 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/535957
TIGECYCLINE FORMULATIONS Aug 4, 2009 Abandoned
Array ( [id] => 6258000 [patent_doc_number] => 20100029771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'TREATMENT OF ADDICTIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/533608 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6106 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029771.pdf [firstpage_image] =>[orig_patent_app_number] => 12533608 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/533608
TREATMENT OF ADDICTIVE DISORDERS Jul 30, 2009 Abandoned
Array ( [id] => 8352077 [patent_doc_number] => 08247406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Composition and method for treatment of MRSA' [patent_app_type] => utility [patent_app_number] => 12/512295 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7406 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12512295 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/512295
Composition and method for treatment of MRSA Jul 29, 2009 Issued
Array ( [id] => 7540425 [patent_doc_number] => 08058268 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Neuroprotective agents for the prevention and treatment of neurodegenerative diseases' [patent_app_type] => utility [patent_app_number] => 12/462182 [patent_app_country] => US [patent_app_date] => 2009-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12325 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058268.pdf [firstpage_image] =>[orig_patent_app_number] => 12462182 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/462182
Neuroprotective agents for the prevention and treatment of neurodegenerative diseases Jul 28, 2009 Issued
Array ( [id] => 7682163 [patent_doc_number] => 20100022645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'PKC-Activating Compounds for the Treatment of Neurodegenerative Diseases' [patent_app_type] => utility [patent_app_number] => 12/510681 [patent_app_country] => US [patent_app_date] => 2009-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11274 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022645.pdf [firstpage_image] =>[orig_patent_app_number] => 12510681 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/510681
PKC-activating compounds for the treatment of neurodegenerative diseases Jul 27, 2009 Issued
Array ( [id] => 8555263 [patent_doc_number] => 08329734 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Topical therapy for migraine' [patent_app_type] => utility [patent_app_number] => 12/460966 [patent_app_country] => US [patent_app_date] => 2009-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10413 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12460966 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/460966
Topical therapy for migraine Jul 26, 2009 Issued
Array ( [id] => 6257481 [patent_doc_number] => 20100029661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Anesthetic compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 12/460954 [patent_app_country] => US [patent_app_date] => 2009-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3349 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029661.pdf [firstpage_image] =>[orig_patent_app_number] => 12460954 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/460954
Anesthetic compositions and methods of use Jul 26, 2009 Issued
Array ( [id] => 8555288 [patent_doc_number] => 08329760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 12/505421 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7944 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12505421 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/505421
Pharmaceutical composition Jul 16, 2009 Issued
Array ( [id] => 5465705 [patent_doc_number] => 20090325905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'METHOD FOR TREATING DISEASES ASSOCIATED WITH ALTERATIONS IN CELLULAR INTEGRITY USING RHO KINASE INHIBITOR COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/492932 [patent_app_country] => US [patent_app_date] => 2009-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 35575 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325905.pdf [firstpage_image] =>[orig_patent_app_number] => 12492932 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/492932
Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds Jun 25, 2009 Issued
Array ( [id] => 9503634 [patent_doc_number] => 08741949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Inhibitors of carnitin-palmitoyl-tranferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue' [patent_app_type] => utility [patent_app_number] => 13/001422 [patent_app_country] => US [patent_app_date] => 2009-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7267 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13001422 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/001422
Inhibitors of carnitin-palmitoyl-tranferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue Jun 24, 2009 Issued
Array ( [id] => 6039551 [patent_doc_number] => 20110092600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING AMINOCYCLOHEXANE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/737283 [patent_app_country] => US [patent_app_date] => 2009-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8992 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092600.pdf [firstpage_image] =>[orig_patent_app_number] => 12737283 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/737283
PHARMACEUTICAL COMPOSITIONS COMPRISING AMINOCYCLOHEXANE DERIVATIVES Jun 24, 2009 Abandoned
Array ( [id] => 5374868 [patent_doc_number] => 20090312429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Administration of nepafenac or derivatives thereof for treating dermatological/keratinization disorders' [patent_app_type] => utility [patent_app_number] => 12/457754 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3700 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312429.pdf [firstpage_image] =>[orig_patent_app_number] => 12457754 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/457754
Administration of nepafenac or derivatives thereof for treating dermatological/keratinization disorders Jun 18, 2009 Abandoned
Array ( [id] => 6628309 [patent_doc_number] => 20100004210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'METHOD AND SUBSTANCES FOR TREATING T-CELL MEDIATED AUTOIMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/474184 [patent_app_country] => US [patent_app_date] => 2009-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6992 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004210.pdf [firstpage_image] =>[orig_patent_app_number] => 12474184 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/474184
Method and substances for treating T-cell mediated autoimmune diseases May 27, 2009 Issued
Array ( [id] => 7490482 [patent_doc_number] => 20110237597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'METHOD OF TREATING PERIPHERAL NERVE SENSORY LOSS USING COMPOUNDS HAVING NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/993457 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15504 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237597.pdf [firstpage_image] =>[orig_patent_app_number] => 12993457 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/993457
METHOD OF TREATING PERIPHERAL NERVE SENSORY LOSS USING COMPOUNDS HAVING NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY May 14, 2009 Abandoned
Array ( [id] => 5386319 [patent_doc_number] => 20090227564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'DRUG FOR PREVENTION AND/OR THERAPY OF ENDOMETRIOSIS' [patent_app_type] => utility [patent_app_number] => 12/464940 [patent_app_country] => US [patent_app_date] => 2009-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2103 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227564.pdf [firstpage_image] =>[orig_patent_app_number] => 12464940 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/464940
DRUG FOR PREVENTION AND/OR THERAPY OF ENDOMETRIOSIS May 12, 2009 Abandoned
Array ( [id] => 6113518 [patent_doc_number] => 20110190309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST' [patent_app_type] => utility [patent_app_number] => 12/992226 [patent_app_country] => US [patent_app_date] => 2009-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27550 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190309.pdf [firstpage_image] =>[orig_patent_app_number] => 12992226 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/992226
PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST May 11, 2009 Abandoned
Menu